The average annual retail cost of specialty drugs used to treat complex diseases such as cancer, rheumatoid arthritis and multiple sclerosis now exceeds the median U.S. household income, according to a report to be published Friday.
Democracy Dies in Darkness
Specialty drugs now cost more than the median household income
November 20, 2015 at 12:01 a.m. EST